National Drinking Water Database
National Drinking Water Database - Chemical Contaminants
Arsenic (total)
Status: Regulated - EPA has established a maximum legal limit in tapwater for this contaminant.
Arsenic contaminates drinking water due to mining runoff, erosion of natural deposits, emissions from glass and electronics processing and the use of arsenical compounds as wood preservatives and pesticides. [read more]
Detected |
Found above health guidelines |
Found above legal limit |
|
|---|---|---|---|
| States | 43 |
43 |
37 |
| Water utilities | 11,173 |
11,173 |
1,724 |
| People Served | 113,356,829 |
113,356,829 |
11,149,291 |
Health Concerns for Arsenic (total):
- Cancer
- Developmental/reproductive toxicity
- Organ system toxicity (non-reproductive)
- Neurotoxicity
- Occupational hazards
- Persistence and bioaccumulation
- Endocrine disruption
- Biochemical or cellular level changes
- Ecotoxicology
- Multiple, additive exposure sources
Arsenic (total) Exposure by State
Water utilities in 43 states have reported detecting Arsenic (total) in treated tap water since 2004, according to EWG's analysis of water quality data supplied by state water agencies.
| State | Water Suppliers with Arsenic (total) contamination | Water suppliers reporting Arsenic (total) above health-based limits | ||
|---|---|---|---|---|
| Systems | Population | Systems | Population | |
| California | 1,237 | 41,950,094 | 1,237 | 41,950,094 |
| Florida | 688 | 12,064,710 | 688 | 12,064,710 |
| Illinois | 741 | 7,809,581 | 741 | 7,809,581 |
| Texas | 1,043 | 5,483,450 | 1,043 | 5,483,450 |
| Arizona | 501 | 4,596,872 | 501 | 4,596,872 |
| Pennsylvania | 336 | 3,736,561 | 336 | 3,736,561 |
| New York | 332 | 3,343,408 | 332 | 3,343,408 |
| New Jersey | 61 | 3,109,859 | 61 | 3,109,859 |
| Ohio | 287 | 2,698,921 | 287 | 2,698,921 |
| Indiana | 332 | 2,694,300 | 332 | 2,694,300 |
| Utah | 220 | 2,379,492 | 220 | 2,379,492 |
| Washington | 522 | 2,222,066 | 522 | 2,222,066 |
| Nevada | 132 | 2,090,404 | 132 | 2,090,404 |
| Maryland | 132 | 2,015,661 | 132 | 2,015,661 |
| Wisconsin | 773 | 1,753,465 | 773 | 1,753,465 |
| Oregon | 350 | 1,371,971 | 350 | 1,371,971 |
| Missouri | 261 | 1,338,512 | 261 | 1,338,512 |
| Nebraska | 443 | 1,317,764 | 443 | 1,317,764 |
| Minnesota | 304 | 1,110,732 | 304 | 1,110,732 |
| Oklahoma | 2 | 1,069,000 | 2 | 1,069,000 |
| New Mexico | 144 | 977,554 | 144 | 977,554 |
| Massachusetts | 92 | 933,650 | 92 | 933,650 |
| Idaho | 298 | 756,833 | 298 | 756,833 |
| Iowa | 197 | 701,022 | 197 | 701,022 |
| Delaware | 65 | 664,621 | 65 | 664,621 |
| Connecticut | 26 | 650,241 | 26 | 650,241 |
| District of Columbia | 1 | 581,530 | 1 | 581,530 |
| Michigan | 200 | 524,299 | 200 | 524,299 |
| Maine | 229 | 492,443 | 229 | 492,443 |
| Alaska | 279 | 474,209 | 279 | 474,209 |
| Montana | 241 | 456,405 | 241 | 456,405 |
| Kentucky | 12 | 451,359 | 12 | 451,359 |
| New Hampshire | 483 | 430,398 | 483 | 430,398 |
| South Dakota | 78 | 398,179 | 78 | 398,179 |
| North Carolina | 33 | 198,232 | 33 | 198,232 |
| Hawaii | 1 | 170,921 | 1 | 170,921 |
| Alabama | 5 | 111,465 | 5 | 111,465 |
| Virginia | 2 | 102,949 | 2 | 102,949 |
| Arkansas | 13 | 61,129 | 13 | 61,129 |
| Vermont | 30 | 28,303 | 30 | 28,303 |
| North Dakota | 27 | 19,089 | 27 | 19,089 |
| West Virginia | 12 | 11,688 | 12 | 11,688 |
| Wyoming | 8 | 3,487 | 8 | 3,487 |
| Total | 11,173 | 113,356,829 | 11,173 | 113,356,829 |
The Most Polluted Communities
11,173 water utilities reported detecting Arsenic (total) in tap water since 2004, according to EWG's analysis of water quality data supplied by state water agencies
Ranked by highest average Arsenic (total) level
| Rank | System | Population Served | Positive test results of total reported tests | Average Level (Range) |
|---|---|---|---|---|
| 1 | Tacna Water Co Yuma, AZ | 240 | 1 of 1 | 30 ppb (30 ppb) |
| 2 | Kingston Apartments Rancho Santa Fe, MI | 50 | 1 of 1 | 30 ppb (30 ppb) |
| 3 | Maverick Subd Lasher Construction Caldwell, ID | 90 | 2 of 2 | 30 ppb (30 ppb) |
| 4 | Preston Manor NY | 40 | 4 of 4 | 30 ppb (30 ppb) |
| 5 | City of Devils Lake Devils Lake, ND | 7,222 | 7 of 7 | 30 ppb (30 ppb) |
| 6 | City of Linden Linden, MI | 2,801 | 2 of 2 | 29.67 ppb (29.33 to 30 ppb) |
| 7 | Denlar Apartments - Buildings 17 & 19 Killingworth, CT | 36 | 3 of 3 | 29.33 ppb (28 to 30 ppb) |
| 8 | KB Water Association Soldotna, AK | 170 | 1 of 1 | 29.3 ppb (29.3 ppb) |
| 9 | Sunny Acres Nursing Center Bad Axe, MI | 30 | 2 of 2 | 29 ppb (28 to 30 ppb) |
| 10 | Spring Creek Mhp Pahrump, NV | 4,146 | 2 of 2 | 29 ppb (28.67 to 29.33 ppb) |
Health Based Limits for Arsenic (total)
| Standard | Description | Level |
|---|---|---|
| Maximum Contaminant Limit Goal (MCLG) | A non-enforceable health goal that is set at a level at which no known or anticipated adverse effect on the health of persons occurs and which allows an adequate margin of safety. Source: U.S. Environmental Protection Agency. | 0 ppb |
| California Public Health Goals | Defined by the State of California Office of Environmental Health Hazard Assessment (OEHHA) as the level of contaminant that is allowed in drinking water. For acutely toxic substances, levels are set at which scientific evidence indicates that no known or anticipated adverse effects on health will occur, plus an adequate margin-of safety. PHGs for carcinogens or other substances which can cause chronic disease shall be based solely on health effects without regard to cost impacts and shall be set at levels which OEHHA has determined do not pose any significant risk to health. | <0.01 ppb |
| EPA Human Health Water Quality Criteria | Water quality criteria set by the US EPA provide guidance for states and tribes authorized to establish water quality standards under the Clean Water Act (CWA) to protect human health. These are non-enforceable standards based upon exposure by both drinking water and the contribution of water contamination to other consumed foods. Source: U.S. Environmental Protection Agency. | 0.02 ppb |
| One in one million (10-6) Cancer Risk | The concentration of a chemical in drinking water corresponding to an excess estimated lifetime cancer risk of 1 in 1,000,000. Source: U.S. Environmental Protection Agency. | 0.02 ppb |
| One in ten thousand (10-4) Cancer Risk | The concentration of a chemical in drinking water corresponding to an excess estimated lifetime cancer risk of 1 in 10,000. Source: U.S. Environmental Protection Agency. | 2 ppb |
| Maximum Contaminant Limit (MCL) | The enforceable standard which defines the highest level of a contaminant that is allowed in drinking water. MCLs are set as close to health-based limits (Maximum Contaminant Level Goals, or MCLGs) as feasible using the best available analytical and treatment technologies and taking cost into consideration. Source: U.S. Environmental Protection Agency. | 10 ppb |
| Drinking Water Equivalent Level | A lifetime exposure concentration protective of adverse, noncarcinogenic health effects, that assumes all of the exposure to a contaminant is from drinking water. Source: U.S. Environmental Protection Agency. | 10 ppb |
Testing Summary for Arsenic (total)
| Are tests routinely required for Arsenic (total) by federal law? | Yes |
| Water suppliers reporting tests for Arsenic (total) (2004-2009): | 32,224 of 47,576 |
| Average testing rate for water supplier reporting tests (2004-2009): | 0.5 per year |
Violation Summary for Arsenic (total)
Data from the U.S. Environmental Protection Agency includes the following violations of federal standards for Arsenic (total) since 2004
| Maximum Contaminant Level Exceedance Violations | 3,501 |
| Monitoring Violations | 2,424 |
| Reporting Violations | 1 |
Cancer
| Type of concern: | Reference: |
| Known human carcinogen | Amer Conf of Gov't Industrial Hygienists - Carcinogens |
| Known human carcinogen | EPA Integrated Risk Information System (IRIS) |
| Known human carcinogen | Int'l Agency for Research on Cancer (IARC) - Carcinogens |
| Known human carcinogen | NTP Report on Carcinogens, 11th Edition |
| Possible human carcinogen | California EPA Proposition 65 |
| Cancer - limited evidence | Proposition 65 List of Carcinogens |
| Cancer - limited evidence | A Relational Database of Hazardous Chemicals and Occupational Diseases |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Human Genetics 1979 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Mutation Research 1983 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Mutation Research 2003 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Toxicologist 2003 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Toxicologist 2005 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Mutagenesis 2004 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Toxicologist 2008 |
| One or more animal studies show tumor formation at moderate doses | RTECS®- Zeitschrift fuer Krebsforschung 1942 |
| One or more in vitro tests non-mammalian cells show positive mutation results | RTECS®- Zeitschrift fuer Krebsforschung 1942 |
| One or more in vitro tests on microorganisms show positive mutation results | RTECS®- Mutagenesis 2005 |
Developmental/reproductive toxicity
| Type of concern: | Reference: |
| Possible human developmental toxicant | California EPA Proposition 65 |
| One or more animal studies show reproductive effects at very low doses | RTECS®- Gigiena i Sanitariya 1977 |
| One or more animal studies show reproductive effects at very low doses | RTECS®- Farmakologiya i Toksikologiya (Moscow) 1978 |
| Limited evidence of developmental toxicity | California EPA, Office of Environmental Health Hazard Assessment, 2003 |
| One or more animal studies show reproductive effects at moderate doses | RTECS®- Toxicologist 2003 |
Organ system toxicity (non-reproductive)
| Type of concern: | Reference: |
| Known human respiratory toxicant | EPA Hazardous Air Pollutants |
| One or more animal studies show broad systemic effects at very low doses | RTECS®- Toxicology 1990 |
| One or more animal studies show liver effects at very low doses | RTECS®- Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales 1918 |
| One or more animal studies show kidney or renal system effects at very low doses | RTECS®- Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales 1918 |
| One or more animal studies show cardiovascular effects at low doses | RTECS®- Pediatric Emergency Care 1997 |
| One or more animal studies show blood effects at low doses | RTECS®- Pediatric Emergency Care 1997 |
| One or more animal studies show metabolic effects at low doses | RTECS®- Pediatric Emergency Care 1997 |
| One or more animal studies show gastrointestinal effects at low doses | RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 |
| One or more animal studies show broad systemic effects at low doses | RTECS®- "Vrednie chemichescie veshestva 1993 |
| Classified as toxic or harmful | European Union - Classification & Labelling |
| Limited evidence of gastrointestinal or liver toxicity | Agency for Toxic Substances and Disease Registry, 2004 |
| Limited evidence of sense organ toxicity | Agency for Toxic Substances and Disease Registry, 2004 |
| Limited evidence of respiratory toxicity | US EPA, Air Risk Information Support Center, 1996 |
| Limited evidence of gastrointestinal or liver toxicity | Dossing, M, 1985 |
| Limited evidence of cardiovascular or blood toxicity | California EPA, Office of Environmental Health Hazard Assessment, 2003 |
| Limited evidence of cardiovascular or blood toxicity | A Relational Database of Hazardous Chemicals and Occupational Diseases, 2003 |
| Limited evidence of kidney toxicity | Merck & Co |
| One or more animal studies show classified as toxic effects at moderate doses (low dose studies may be unavailable for this ingredient) | EPA Toxic Release Inventory PBTs |
| One or more animal studies show gastrointestinal effects at moderate doses (low dose studies may be unavailable for this ingredient) | RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | RTECS®- Archivio di Science Biologiche (Bologna) 1938 |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | RTECS®- "Vrednie chemichescie veshestva 1993 |
| One or more animal studies show gastrointestinal effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 |
| One or more animal studies show kidney or renal system effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 |
| One or more animal studies show blood effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 |
| Classified as not expected to be potentially toxic or harmful | Environment Canada Domestic Substance List |
| Classified as a low human health priority | Environment Canada Domestic Substance List |
Neurotoxicity
| Type of concern: | Reference: |
| One or more animal studies show brain, nervous system, or behavioral effect effects at low doses | RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 |
| One or more animal studies show brain, nervous system, or behavioral effect effects at moderate doses | RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 |
Occupational hazards
| Type of concern: | Reference: |
| Allowed workplace exposures restricted to very low doses | RTECS®- TLV/BEI,2006 |
| Allowed workplace exposures restricted to very low doses | RTECS®- TLV/BEI,2007 |
| Allowed workplace exposures restricted to low doses | European Union - Classification & Labelling |
| Allowed workplace exposures restricted to high doses | National Library of Medicine HazMap |
| Single case study detailing occupational hazards | National Library of Medicine HazMap |
| Single case study detailing occupational hazards | Frazier , L, 1998 |
Persistence and bioaccumulation
| Type of concern: | Reference: |
| Persistent, bioaccumulative in wildlife | Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) |
| Not suspected to be bioaccumulative | Environment Canada Domestic Substance List |
Endocrine disruption
| Type of concern: | Reference: |
| Limited evidence of endocrine disruption | Keith, L, 1997 |
| endocrine - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | Our Stolen Future Endocrine Disruptors |
Biochemical or cellular level changes
| Type of concern: | Reference: |
| One or more animal studies show biochemical changes at very low doses where the human health implications are not yet well understood | RTECS®- Toxicologist 2005 |
Ecotoxicology
| Type of concern: | Reference: |
| Wildlife and environmental toxicity | European Union - Classification & Labelling |
| Wildlife and environmental toxicity | EPA Clean Water Act - Priority Pollutants |
| Not suspected to be an environmental toxin | Environment Canada Domestic Substance List |
Multiple, additive exposure sources
| Type of concern: | Reference: |
| Designated as safe for general or specific, limited use in food | FDA Food Additive Status |
Government, industry, academic studies and classifications
| government/industry list/academic study | appears on list as | classification(s) |
| European Union - Classification & Labelling | ARSENIC | •Toxic •Toxic by inhalation and ingestion •Dangerous for the environment •Very toxic to aquatic organisms |
| European Union - Classification & Labelling | ARSENIC COMPOUNDS, WITH THE EXCEPTION OF THOSE SPECIFIED ELSEWHERE IN THIS ANNEX | •Toxic •Toxic by inhalation and ingestion •Dangerous for the environment •Very toxic to aquatic organisms |
| Amer Conf of Gov't Industrial Hygienists - Carcinogens | ARSENIC, ELEMENTAL AND INORGANIC COMPOUNDS AS AS | •Confirmed human carcinogen (ACGIH classification A1) |
| FDA Food Additive Status | ARSENIC | • Used in animal feed • Food additive: food additive for which a petition has been filed and a regulation issued • 2 parts per million - As residue in liver and kidney of swine - CFR556.60 • 2 parts per million - As residue in edible bypdts of chickens and turkeys - same Code of Federal Regulations reference as appears earlier in paragraph • 0.5 parts per million - As residue in muscle meat of chickens and turkeys • in eggs • and in muscle meat and by-products (other than kidney and li |
| Association of Occupational and Environmental Clinics | ARSENIC | • o |
| Canada - Prohibited and Restricted Cosmetics Ingredients | ARSENIC | •Prohibited from use in Canadian cosmetics |
| EPA Clean Water Act - Priority Pollutants | ARSENIC | •Priority water pollutant under the Clean Water Act |
| Environment Canada Domestic Substance List | ARSENIC | •This chemical was deemed a low human health priority and was NOT flagged by CEPA for further attention. The chemical was flagged for suspected persistence. |
| EPA Integrated Risk Information System (IRIS) | ARSENIC, INORGANIC | •Group A: Human carcinogen according (EPA classification) |
| EPA Hazardous Air Pollutants | ARSENIC COMPOUNDS (INORGANIC INCLUDING ARSINE) | •Hazardous air pollutant under Clean Air Act |
| National Library of Medicine HazMap | ARSENIC AND COMPOUNDS | •Anemia: Anemia, Aplastic; •Skin Sensitizer - An agent that can induce an allergic reaction in the skin or lungs: Yes; •Reproductive Toxin - A chemical that is toxic to the reproductive system, including defects in the progeny and injury to male and female reproductive function: Yes;RS: EPA regulates emissions from copper smelters, glass manufacturing plants, and other facilities. EPA also regulates arsenic in water and use of arsenic in pesticides. Inorganic arsenic compounds are no longer |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | ARSENIC AND ARSENIC COMPOUNDS | •IARC Group 1: carcinogenic to humans (International Agency for Research on Carcinogens) |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | ARSENIC COMPOUNDS | •IARC Group 1: carcinogenic to humans (International Agency for Research on Carcinogens) |
| NTP Report on Carcinogens, 11th Edition | ARSENIC COMPOUNDS, INORGANIC | •Known human carcinogen (National Toxicology Program classification) |
| Our Stolen Future Endocrine Disruptors | ARSENIC | • |
| Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | ARSENIC COMPOUNDS | •Persistent toxicant under Canada's Accelerated Reduction/Elimination of Toxics program - targeted for elimination or reduction |
| EPA Toxic Release Inventory PBTs | DISSOLVEDARSENIC | •Toxic, U.S. Environmental Protection Agency Toxics Release Inventory programs |
| EPA Toxic Release Inventory PBTs | ARSENIC COMPOUNDS | •Toxic, U.S. Environmental Protection Agency Toxics Release Inventory programs |
| California EPA Proposition 65 | ARSENIC (INORGANIC ARSENIC COMPOUNDS) | •Carcinogen: California Proposition 65 |
| California EPA Proposition 65 | ARSENIC (INORGANIC OXIDES) | •Developmental toxin: California Proposition 65 |
| Agency for Toxic Substances and Disease Registry, 2004 | ARSENIC | •Gastrointestinal or liver toxicity hazards: suspected |
| Agency for Toxic Substances and Disease Registry, 2004 | ARSENIC | •Skin or sense organ toxicity hazards: suspected |
| Benowitz, N, 1992 | ARSENIC | •Cardiovascular or blood toxicity hazards: suspected |
| US EPA, Air Risk Information Support Center, 1996 | ARSENIC | •Respiratory toxicity hazards: suspected |
| US EPA, Air Risk Information Support Center, 1984 | ARSENIC | •Kidney toxicity hazards: suspected |
| Frazier , L, 1998 | ARSENIC | •Reproductive toxicity hazards: suspected |
| Keith, L, 1997 | ARSENIC | •Endocrine toxicity hazards: suspected |
| Dossing, M, 1985 | ARSENIC (ORGANIC OR INORGANIC COMPOUNDS) | •Gastrointestinal or liver toxicity hazards: suspected |
| California EPA, Office of Environmental Health Hazard Assessment, 2003 | ARSENIC (ORGANIC OR INORGANIC COMPOUNDS) | •Cardiovascular or blood toxicity hazards: suspected |
| California EPA, Office of Environmental Health Hazard Assessment, 2003 | ARSENIC (ORGANIC OR INORGANIC COMPOUNDS) | •Developmental toxicity hazards: suspected |
| Proposition 65 List of Carcinogens | ARSENIC (ORGANIC OR INORGANIC COMPOUNDS) | •Cancer hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases | ARSENIC COMPOUNDS | •Cancer hazards: suspected |
| A Relational Database of Hazardous Chemicals and Occupational Diseases, 2003 | ARSENIC COMPOUNDS | •Cardiovascular or blood toxicity hazards: suspected |
| Merck & Co | ARSENIC COMPOUNDS | •Kidney toxicity hazards: suspected |
| California EPA, Office of Environmental Health Hazard Assessment, 2003 | ARSENIC COMPOUNDS | •Developmental toxicity hazards: suspected |
| RTECS®- TLV/BEI,2006 | ARSENIC | • occupationally related - ACGIH TLV (human TWA) |
| RTECS®- TLV/BEI,2007 | ARSENIC | • occupationally related - ACGIH TLV (human TWA) |
| RTECS®- "Vrednie chemichescie veshestva 1993 | ARSENIC | • broad systemic - Broad systemic toxicity (mouse LD50) |
| RTECS®- Archivio di Science Biologiche (Bologna) 1938 | ARSENIC | • broad systemic - Broad systemic toxicity (rabbit LDLo) |
| RTECS®- Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales 1918 | ARSENIC | • liver - Fatty liver degeneration (guinea pig LDLo) • kidney or renal system - Other changes (guinea pig LDLo) |
| RTECS®- Farmakologiya i Toksikologiya (Moscow) 1978 | ARSENIC | • reproductive - Musculoskeletal system (rat TDLo) |
| RTECS®- Gigiena i Sanitariya 1977 | ARSENIC | • reproductive - Post-implantation mortality (rat TDLo) • reproductive - Pre-implantation mortality (rat TDLo) |
| RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 | ARSENIC | • brain, nervous system, or behavioral effect - Ataxia (mouse LD50) • blood - Changes in cell count (unspecified) (rat TDLo) • gastrointestinal - Hypermotility, diarrhea (mouse LD50) • kidney or renal system - Interstitial nephritis (rat TDLo) • gastrointestinal - Other changes (rat TDLo) |
| RTECS®- Human Genetics 1979 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis ( human unr) |
| RTECS®- Human Genetics 1979 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis ( human unr) |
| RTECS®- Mutagenesis 2004 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis ( human lym) |
| RTECS®- Mutagenesis 2005 | ARSENIC | • mutagenic - Positive mutation assay: Micronucleus test (other fish mul) |
| RTECS®- Mutation Research 1983 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis (mouse orl) |
| RTECS®- Mutation Research 2003 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis ( human orl) • mutagenic - Positive mutation assay: Sister Chromatid Exchange ( human orl) |
| RTECS®- Mutation Research 1983 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis (mouse orl) |
| RTECS®- Mutation Research 2003 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis ( human orl) • mutagenic - Positive mutation assay: Sister Chromatid Exchange ( human orl) |
| RTECS®- Pediatric Emergency Care 1997 | ARSENIC | • blood - Changes in leucocyte (WBC) count (child TDLo) • cardiovascular - EKG changes not diagnostic of above (child TDLo) • metabolic - Metabolic acidosis (child TDLo) |
| RTECS®- Toxicologist 2005 | ARSENIC | • mutagenic - Positive mutation assay: DNA Damage (mouse fbr) |
| RTECS®- Toxicologist 2005 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis ( human lng) |
| RTECS®- Toxicologist 2005 | ARSENIC | • biochemical - Other (mouse TDLo) |
| RTECS®- Toxicologist 2003 | ARSENIC | • reproductive - Hepatobiliary system (mouse TDLo) |
| RTECS®- Toxicologist 2003 | ARSENIC | • mutagenic - Positive mutation assay: DNA Damage ( human lng) |
| RTECS®- Toxicologist 2003 | ARSENIC | • immune system - Uncharacterized (mouse TDLo) |
| RTECS®- Toxicologist 2008 | ARSENIC | • mutagenic - Positive mutation assay: DNA Damage ( human lym) |
| RTECS®- Toxicologist 2005 | ARSENIC | • mutagenic - Positive mutation assay: DNA Damage (mouse fbr) |
| RTECS®- Toxicologist 2005 | ARSENIC | • mutagenic - Positive mutation assay: Cytogenetic Analysis ( human lng) |
| RTECS®- Toxicologist 2003 | ARSENIC | • mutagenic - Positive mutation assay: DNA Damage ( human lng) |
| RTECS®- Toxicology 1990 | ARSENIC | • broad systemic - Broad systemic toxicity (rat LD50) |
| RTECS®- Zeitschrift fuer Krebsforschung 1942 | ARSENIC | • mutagenic - liver tumor formations - equivocal (rabbit TDLo) • cancer - respiratory tumor formations - equivocal (rabbit TDLo) |
references
| government/industry list/academic study | reference |
| European Union - Classification & Labelling | CPS&Q (Consumer Products Safety & Quality) formely known as ECB (European Chemicals Bureau). 2008. Classification and Labelling: Chemicals: Annex VI of Directive 67/548/EEC through the 31st ATP. |
| Amer Conf of Gov't Industrial Hygienists - Carcinogens | ACGIH (American Conference of Governmental Industrial Hygienists) 2008. ACGIH cancer classification system. www.acgih.org. |
| FDA Food Additive Status | FDA (U.S. Food and Drug Administration) 2006. Food Additive Status List. Downloaded from http://www.cfsan.fda.gov/%7Edms/opa-appa.html, Oct 16, 2006. |
| Association of Occupational and Environmental Clinics | AOEC (Association of Occupational and Environmental Clinics). 2009. AEOC exposures codes and asthmagen designation. |
| Canada - Prohibited and Restricted Cosmetics Ingredients | Health Canada. 2007. List of Prohibited and Restricted Cosmetic Ingredients. Canada's Cosmetic Ingredient Hotlist. March 2007. |
| EPA Clean Water Act - Priority Pollutants | |
| Environment Canada Domestic Substance List | EC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry. |
| EPA Integrated Risk Information System (IRIS) | EPA (U.S. Environmental Protection Agency). 2008. Integrated Risk Information System (IRIS). Evidence for human carcinogenicity based on 1986-2005 guidelines. |
| EPA Hazardous Air Pollutants | EPA (U.S. Environmental Protection Agency). 2005. Office of Air. The 112(b)1 Hazardous Air Pollutants List (as modified). Last modified: 12 Dec 2005. |
| National Library of Medicine HazMap | NLM (National Library of Medicine). 2006. HazMap — Occupational Exposure to Hazardous Agents. |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | IARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures). |
| NTP Report on Carcinogens, 11th Edition | NTP (National Toxicology Program). 2005. Report on Carcinogens, Eleventh Edition; U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. |
| Our Stolen Future Endocrine Disruptors | Colborn T, D Dumanoski, JP Myers. 2006. Widespread Pollutants with Endocrine-disrupting Effects. Updated from original listing in "Our Stolen Future" (1996). |
| Canada PBTs - Accelerated Reduction/Elimination of Toxics (ARET) | EC (Environment Canada). 1994. Accelerated Reduction/Elimination of Toxics (ARET). ARET substance list of persistent, bioaccumulative and toxic chemicals. |
| EPA Toxic Release Inventory PBTs | EPA (U.S. Environmental Protection Agency). 1999. Toxics Release Inventory Program. PBT Chemical Rule. |
| California EPA Proposition 65 | California EPA (California Environmental Protection Agency). 9/2008. Office of Environmental Health Hazard Assessment. Safe Drinking Water and Toxic Enforcement Act of 1986. Chemicals known to the State to cause cancer or reproductive toxicity. |
| Scorecard.org Toxicity Information | Agency for Toxic Substances and Disease Registry. Minimal risk Levels for Hazardous Substances. January 2004. http://www.atsdr.cdc.gov/mrls.html, DiPalma, J.A., J. Cunningham, J. Herrera, T. McCaffery, and D. Wolf. Occupational and Industrial Toxin Exposures and the Gastrointestinal Tract. American Journal of Gastroenterology. 86(9): 1107-1117. 1991. (Table 2: Selected Agents with Purported Digestive System Injury)., US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., Malachowsky, M.J. Health Effects of Toxic Substances. Government Institutes. Rockville, MD 1995., National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995., Zimmerman, H.J. and J.H. Lewis. Chemical- and Toxin-Induced Hepatotoxicity. Gastroenterology Clinics of North America. 24(4): 1027-1045. 1995. (Table 3: Forms of environmental hepatic injury). |
| Scorecard.org Toxicity Information | Agency for Toxic Substances and Disease Registry. Minimal risk Levels for Hazardous Substances. January 2004. http://www.atsdr.cdc.gov/mrls.html, US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation. |
| Scorecard.org Toxicity Information | Benowitz, N.L. Cardiotoxicity in the Workplace. Occupational Medicine. 7(3): 465-477. 1992. (Table 1: Chemical Toxins and Cardiovascular Disease)., US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., Kristensen, T. S. Cardiovascular Diseases and the Work Environment. Scandinavian Journal of Work and Environmental Health. 15:245-264. 1989. (Table 5: Classification of possible risk factors for cardiovascular disease in the work environment)., LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., Malachowsky, M.J. Health Effects of Toxic Substances. Government Institutes. Rockville, MD 1995., California EPA, Office of Environmental Health Hazard Assessment. Air Toxics Hot Spots Program Risk Assessment Guidelines, Part III: Technical Support Document 'Determination of Noncancer Chronic Reference Exposure Levels'. Includes all Chronic Reference Exposure Levels (CRELs) adopted by OEHHA as of August 2003 (http://www.oehha.ca.gov/air/chronic_rels/AllChrels.html, plus draft CRELS proposed through March 2004 (http://www.oehha.ca.gov/air/chronic_rels/index.html., National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances. See Environmental Defense's Suspect Hazard Identification documentation., Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, Klaassen, C., M. Amdur and J. Doull (eds.). Casarett and Doull's Toxicology. The Basic Science of Poisons, 5th Ed. Pergamon Press, NY. 1996., LaDou, J. (ed.). Occupational Medicine. Appleton & Lange, Norwalk, CN. 1990., Lu, F.C. Basic Toxicology. 2nd Edition. 1991., Nemery, B. Metal Toxicity and the Respiratory Tract. European Respiratory Journal. 3(2): 202-219. 1990.(Table 1: Summary of pulmonary toxicity of metals). |
| Scorecard.org Toxicity Information | US EPA, Air Risk Information Support Center. Health Effects Notebook for Hazardous Air Pollutants. http://www.epa.gov/ttnatw01/hlthef/hapindex.html, Landrigan, P.J., Goyer, R.A. Clarkson, T.W., Sandler, D.P., Smith, J.H., Thun, M.J., and R. Wedeen. The Work-Relatedness of Renal Disease. Archives of Environmental Health. 39(3): 225-230. 1984. (Table 2: Estimated Numbers of Workers in the United States with Potential Occupational Exposures to Known or Suspect Nephrotoxins)., Merck & Co. The Merck Manual of Diagnosis and Therapy. TABLE 226-1. Common Nephrotoxic Agents http://www.merck.com/pubs/mmanual/tables/226tb1.htm, Stacey, N.H. Occupational Toxicology. Taylor & Francis. 1995. |
| Scorecard.org Toxicity Information | Frazier , L. and M. L. Hage (eds.). Reproductive Hazards of the Workplace, Wiley Europe, 1998. Table 10 (Partial List of Reproductive Toxicants) available at http://www.pharmacy.ohio-state.edu/homepage/safety/chemhygiene_table_repro.pdf., California EPA, Office of Environmental Health Hazard Assessment. Acute Reference Exposure Levels (RELs), Averaging Times, and Toxicologic Endpoints. Includes all Acute Reference Exposure Levels (ARELs) developed by OEHHA through May 2000http://www.oehha.org/air/acute_rels/allAcRELs.html |
| Scorecard.org Toxicity Information | Keith, L.H. (ed.). Environmental Endocrine Disruptors. John Wiley & Sons, NY. 1997. http://www.wileyeurope.com/cda/product/0,,0471191450%7Cdesc%7C3037,00.html, World Wildlife Fund. Our Stolen Future. Widespread Pollutants with Endocrine-disrupting Effects. http://www.ourstolenfuture.org/Basics/chemlist.htm. The WWF list is derived from references detailed at http://www.ourstolenfuture.org/Sources/chemsources.htm and was originally published in: Colborn, T., F.S. vom Saal, and A.M. Soto. Developmental Effects of Endocrine-Disrupting Chemicals In Wildlife and Humans. Environmental Health Perspectives 101(5): 378-384. 1993. |
| Scorecard.org Toxicity Information | Dossing, M. and P. Skinhoj. Occupational Liver Injury. Present State of Knowledge and Future Perspectives. International Archives of Occupational and Environmental Health. 56:1-21. 1985. (Table 2: Chemically induced liver injury: morphologic features and examples of confirmed and suspected causative agents)., Zimmerman, H.J. and J.H. Lewis. Chemical- and Toxin-Induced Hepatotoxicity. Gastroenterology Clinics of North America. 24(4): 1027-1045. 1995. (Table 3: Forms of environmental hepatic injury). |
| Scorecard.org Toxicity Information | California EPA, Office of Environmental Health Hazard Assessment. Air Toxics Hot Spots Program Risk Assessment Guidelines, Part III: Technical Support Document 'Determination of Noncancer Chronic Reference Exposure Levels'. Includes all Chronic Reference Exposure Levels (CRELs) adopted by OEHHA as of August 2003 (http://www.oehha.ca.gov/air/chronic_rels/AllChrels.html, plus draft CRELS proposed through March 2004 (http://www.oehha.ca.gov/air/chronic_rels/index.html. |
| Scorecard.org Toxicity Information | California EPA, Office of Environmental Health Hazard Assessment. Air Toxics Hot Spots Program Risk Assessment Guidelines, Part III: Technical Support Document 'Determination of Noncancer Chronic Reference Exposure Levels'. Includes all Chronic Reference Exposure Levels (CRELs) adopted by OEHHA as of August 2003 (http://www.oehha.ca.gov/air/chronic_rels/AllChrels.html, plus draft CRELS proposed through March 2004 (http://www.oehha.ca.gov/air/chronic_rels/index.html., Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html.-MC |
| Scorecard.org Toxicity Information | Proposition 65 List of Carcinogens (July 2004) can be obtained from http://www.oehha.ca.gov/prop65/prop65_list/Newlist.html.-MC |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, World Health Organization, International Agency for Research on Cancer. IARC Monographs Programme on the Evaluation of Carcinogenic Risks to Humans. Lists of Group 1, 2a, and 2b substances can be obtained at http://monographs.iarc.fr/monoeval/grlist.html. |
| Scorecard.org Toxicity Information | A Relational Database of Hazardous Chemicals and Occupational Diseases. Browse Haz-Map by Adverse Effects http://hazmap.nlm.nih.gov/hazmapadv.html, California EPA, Office of Environmental Health Hazard Assessment. Air Toxics Hot Spots Program Risk Assessment Guidelines, Part III: Technical Support Document 'Determination of Noncancer Chronic Reference Exposure Levels'. Includes all Chronic Reference Exposure Levels (CRELs) adopted by OEHHA as of August 2003 (http://www.oehha.ca.gov/air/chronic_rels/AllChrels.html, plus draft CRELS proposed through March 2004 (http://www.oehha.ca.gov/air/chronic_rels/index.html. |
| Scorecard.org Toxicity Information | Merck & Co. The Merck Manual of Diagnosis and Therapy. TABLE 226-1. Common Nephrotoxic Agents http://www.merck.com/pubs/mmanual/tables/226tb1.htm |
| Scorecard.org Toxicity Information | California EPA, Office of Environmental Health Hazard Assessment. Air Toxics Hot Spots Program Risk Assessment Guidelines, Part III: Technical Support Document 'Determination of Noncancer Chronic Reference Exposure Levels'. Includes all Chronic Reference Exposure Levels (CRELs) adopted by OEHHA as of August 2003 (http://www.oehha.ca.gov/air/chronic_rels/AllChrels.html, plus draft CRELS proposed through March 2004 (http://www.oehha.ca.gov/air/chronic_rels/index.html. |
| RTECS®- TLV/BEI,2006 | RTECS®- TLV/BEI,2006 |
| RTECS®- TLV/BEI,2007 | RTECS®- TLV/BEI,2007 |
| RTECS®- "Vrednie chemichescie veshestva 1993 | RTECS®- "Vrednie chemichescie veshestva. Neorganicheskie soedinenia elementov V-VII groopp" (Hazardous substances. Inornanic substances containing V-VII group elements), Bandman A.L. et al., Chimia, 1989. -,87,1993 |
| RTECS®- Archivio di Science Biologiche (Bologna) 1938 | RTECS®- Archivio di Science Biologiche (Bologna). (Bologna, Italy) V.1-62, 1919-78. Discontinued. 24,442,1938 |
| RTECS®- Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales 1918 | RTECS®- Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849- 81,164,1918 |
| RTECS®- Farmakologiya i Toksikologiya (Moscow) 1978 | RTECS®- Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939- 41,620,1978 |
| RTECS®- Gigiena i Sanitariya 1977 | RTECS®- Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1- 1936- 42(8),30,1977 |
| RTECS®- Gigiena Truda i Professional'nye Zabolevaniya 1987 | RTECS®- Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-36, 1957-1992. For publisher information, see MTPEEI 31(12),53,1987 |
| RTECS®- Human Genetics 1979 | RTECS®- Human Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.31- 48,1,1979 |
| RTECS®- Human Genetics 1979 | RTECS®- Human Genetics. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.31- 1976- 48,1,1979 |
| RTECS®- Mutagenesis 2004 | RTECS®- Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 19,223,2004 |
| RTECS®- Mutagenesis 2005 | RTECS®- Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 20,291,2005 |
| RTECS®- Mutation Research 1983 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 113,293,1983 |
| RTECS®- Mutation Research 2003 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 534,133,2003 |
| RTECS®- Mutation Research 1983 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 113,293,1983 |
| RTECS®- Mutation Research 2003 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 534,133,2003 |
| RTECS®- Pediatric Emergency Care 1997 | RTECS®- Pediatric Emergency Care. (Williams & Wilkins, 428 E. Preston St., Baltimore, MD 21202) V.1- -1985 13,394,1997 |
| RTECS®- Toxicologist 2005 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 44,237,2005 |
| RTECS®- Toxicologist 2005 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 44,31,2005 |
| RTECS®- Toxicologist 2005 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 44,32,2005 |
| RTECS®- Toxicologist 2003 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 72,214,2003 |
| RTECS®- Toxicologist 2003 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 72,219,2003 |
| RTECS®- Toxicologist 2003 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- -1981 72,376,2003 |
| RTECS®- Toxicologist 2008 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- 12,430,2008 |
| RTECS®- Toxicologist 2005 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- 44,237,2005 |
| RTECS®- Toxicologist 2005 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- 44,31,2005 |
| RTECS®- Toxicologist 2003 | RTECS®- Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- 72,219,2003 |
| RTECS®- Toxicology 1990 | RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- 64,191,1990 |
| RTECS®- Zeitschrift fuer Krebsforschung 1942 | RTECS®- Zeitschrift fuer Krebsforschung. (Berlin, Fed. Rep. Ger.) V.1-75, 1903-71. For publisher information, see JCROD7. 52,425,1942 |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.
